16 results
8-K
EX-2.1
MIRM
Mirum Pharmaceuticals Inc
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
, all “Material Adverse Effect” qualifications and other materiality qualifications contained in such representations and warranties shall … Representations of Seller contained in this Agreement that are qualified by “Material Adverse Effect” qualifications and other materiality qualifications
8-K
MIRM
Mirum Pharmaceuticals Inc
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
and warranties set forth in the Agreement (subject to customary materiality qualifiers) and material compliance with covenants set forth in the Agreement and (v … to standards of materiality applicable to the contracting parties that differ from those applicable to security holders of the Company. Investors
8-K
EX-10.1
bjmgo 545n
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
8-K
EX-10.1
i3gcurz
19 Nov 21
Entry into a Material Definitive Agreement
6:08am
8-K
EX-10.1
lxcbm zclpbh0zxf9
29 Sep 21
U.S. FDA Approves LIVMARLI (maralixibat) as the First and Only Approved Medication for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome One Year of Age and Older
4:42pm
8-K
EX-99.2
5rdbmtlr2mrmtl84w
10 Dec 20
Revenue Interest Purchase Agreement
9:11am
8-K
EX-99.1
18rj s9c3hggegyqdihy
10 Dec 20
Revenue Interest Purchase Agreement
9:11am
S-3
EX-1.2
tr4wwrguviwz 6hlq
3 Aug 20
Shelf registration
9:00am
S-1/A
EX-10.18
ok14 qz5hpxckjp
8 Jul 19
IPO registration (amended)
6:43am
S-1
EX-10.20
q4j1g1c
21 Jun 19
IPO registration
3:24pm
S-1
EX-10.18
hjmsj
21 Jun 19
IPO registration
3:24pm
DRS
EX-10.18
dqamcn
18 Apr 19
Draft registration statement
12:00am
DRS
EX-10.20
odqia7wiznw86
18 Apr 19
Draft registration statement
12:00am
- Prev
- 1
- Next